Join the club for FREE to access the whole archive and other member benefits.
Key points from article :
It is focused on the twofold path of
(a) establishing patient-funded trials of potentially useful therapies in the longevity science space
(b) packaging participation in trials and later purchase of therapies via medical tourism
The point is not Ascendance Biomedical today, it is the potential Ascendance Biomedical of a few years from now.
Click on resource name for more details.
Drug development company focused on the senolytic technology to fight age-related diseases
Non-profit organization focused on transforming the way the world researches and treats age-related diseases
